ELOVL4

ELOVL Fatty Acid Elongase 4

Gene Information Card

Symbol ELOVL4
Full Name ELOVL Fatty Acid Elongase 4
Gene Type Protein coding
Chromosomal Location 6q14.1
NCBI Gene ID 6785 ncbi.nlm.nih.gov/gene/6785
Ensembl ID ENSG00000118402
UniProt ID Q9GZR5
OMIM ID 605512
HGNC ID 14415
Aliases Ssc2, FLJ25084, MGC125294, MGC125295

Description

ELOVL4 encodes a member of the elongation of very long chain fatty acids (ELOVL) protein family. This enzyme is involved in the biosynthesis of very long-chain fatty acids (VLCFAs) with chain lengths of 26 or more carbons, which are critical for the structure and function of the retina, brain, skin, and other tissues. Mutations in ELOVL4 are associated with autosomal dominant Stargardt disease (STGD3) and spinocerebellar ataxia type 34 (SCA34).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Stargardt disease 3 (STGD3) Dominant-negative or haploinsufficiency leading to reduced VLCFA synthesis in photoreceptor cells, causing retinal degeneration. ClinVar, OMIM
Spinocerebellar ataxia 34 (SCA34) Missense mutations (e.g., p.Arg246Cys) impair enzyme activity, leading to Purkinje cell degeneration and ataxia. ClinVar, OMIM
Erythrokeratodermia variabilis et progressiva (EKVP) Mutations in ELOVL4 disrupt skin barrier function due to abnormal VLCFA composition. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 7.2 Medium
Retina 12.5 High
Skin 5.8 Medium
Testis 4.1 Low
Adipose tissue 2.3 Low
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (retinal pigment epithelium) 15.3 High expression
SH-SY5Y (neuroblastoma) 8.7 Medium expression
HaCaT (keratinocyte) 6.4 Medium expression
HepG2 (hepatocellular carcinoma) 1.2 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.810C>G (p.Tyr270*) Nonsense Rare Truncated protein; loss of function associated with STGD3
c.736C>T (p.Arg246Cys) Missense Rare Impaired enzyme activity; associated with SCA34
c.788A>G (p.Asn263Ser) Missense Rare Reduced VLCFA elongation; linked to EKVP
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Tyr270*) lead to truncated, non-functional protein, causing haploinsufficiency in Stargardt disease.

Gain of Function (GOF)

No gain-of-function mutations reported for ELOVL4.

Dominant Negative (DN)

Missense mutations (e.g., p.Arg246Cys) may exert dominant-negative effects by interfering with wild-type enzyme complex formation, as seen in SCA34.

Gene Ontology (GO)

fatty acid elongase activity (GO:0009922) fatty acid biosynthetic process (GO:0006633)
• integral component of membrane (GO:0016021) endoplasmic reticulum (GO:0005783)

Pathways

Very long-chain fatty acid biosynthesis (Reactome: R-HSA-2046106)
Sphingolipid metabolism (KEGG: hsa00600)

Protein Summary

ELOVL4 is a 314-amino acid transmembrane protein localized to the endoplasmic reticulum. It catalyzes the condensation of malonyl-CoA with long-chain acyl-CoA substrates to extend fatty acids beyond C26. The protein contains a conserved histidine-rich motif essential for enzymatic activity. Mutations affecting the C-terminal region disrupt protein stability and localization, leading to disease.

Related Products

Product name Cat.No. Species Gene ID
ELOVL4 Knockout HEK293 Cell Line EDJ-KQ3151 Human 6785 Details Get a Quote
ELOVL4 Knockout HeLa Cell Line EDJ-KQ23165 Human 6785 Details Get a Quote
ELOVL4 Knockout A-549 Cell Line EDJ-KQ24550 Human 6785 Details Get a Quote
ELOVL4 Knockout HCT 116 Cell Line EDJ-KQ71544 Human 6785 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: